Hovione, headquartered in Loures, Portugal, is a leading pharmaceutical Contract Development and Manufacturing Organization (CDMO) that specializes in the development and production of active pharmaceutical ingredients (APIs) and drug product intermediates. The company was founded in 1959 by Ivan Villax and Diane Villax and has grown to become a global player in the pharmaceutical industry. Hovione offers a wide range of services including process development, formulation development, particle engineering, and manufacturing services for both new chemical entities and generic drugs.

The company operates state-of-the-art facilities in four different continents, including Portugal, the United States, Ireland, and China. In addition to its manufacturing capabilities, Hovione has established strategic partnerships and joint ventures across the globe. Notably, the company has a joint venture with ChipScreen Biosciences to develop and manufacture small molecule drugs in China.

This partnership strengthens Hovione's presence in the Asian market and allows for greater access to China's growing pharmaceutical industry. Hovione has a strong market position and is recognized for its innovation and high-quality products. The company has a global customer base and serves clients from both the pharmaceutical and biotech industries.

With more than 60 years of industry experience, Hovione has built a reputation for its technical expertise and commitment to customer satisfaction. Over the years, Hovione has achieved several milestones and strategic changes that have contributed to its growth. In 2018, the company inaugurated a new commercial manufacturing facility in New Jersey, USA, expanding its production capacity and increasing its presence in the North American market.

Additionally, in 2020, Hovione acquired a facility in New Jersey from an international pharmaceutical company, further strengthening its manufacturing capabilities. Currently, Hovione continues to be a significant player in the global pharmaceutical industry. The company is dedicated to developing innovative solutions and expanding its global reach.

With a strong focus on customer service and technical excellence, Hovione remains at the forefront of the CDMO market, delivering high-quality products and services to its global customer base